Savaria Corp

SIS

Equity

ISIN null / Valor 1385257

Toronto Stock Exchange (2025-11-21)

CAD 21.03+0.48%

Savaria Corp
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Savaria Corporation is a global leader in the accessibility industry, specializing in the design, manufacturing, and distribution of a wide range of mobility products. The company's extensive product portfolio includes home elevators, commercial lifts, stairlifts, ceiling lifts, and adapted vehicles, catering to individuals with mobility challenges. Additionally, through its Span division, Savaria offers medical beds and therapeutic surfaces. With manufacturing facilities strategically located in North America, Europe, and China, Savaria is well-positioned to serve global markets and customize solutions to meet specific customer needs. The company has expanded its reach through strategic acquisitions, such as the purchase of Handicare AB, enhancing its presence in the European and Far East markets. Savaria's leadership team, including executives like Jean-Philippe DeMontigny and Clare Brophy, brings extensive experience in growth strategies and market expansion, further solidifying its position in the accessibility sector.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Fourth-quarter revenue reached $216.8 million, up by $4.7 million or 2.2% year-over-year. This growth was driven by organic increases of 6.2% and a positive foreign exchange impact of 2.3%, partially offset by the divestiture of Norwegian operations.

Segment Performance

The Accessibility segment, which constitutes 80% of Q4 revenue, saw an increase of $7.2 million or 4.3%, fueled by a strong organic growth rate of 9.5%. Conversely, the Patient Care segment, accounting for 20% of revenue, experienced a decline of $2.5 million or 5.4%, with a 5.9% organic contraction.

Operating Income

Operating income remained stable at $19.8 million, maintaining an operating margin of 9.2% compared to 9.4% in the same quarter last year.

Adjusted EBITDA

Adjusted EBITDA for Q4 2023 was $35.1 million, up from $33.3 million in Q4 2022, resulting in an improved EBITDA margin of 16.2%, up from 15.7% the previous year.

Strategic Initiatives

Savaria continued to advance its Savaria One program during the quarter, focusing on sales growth, pricing optimization, and operational efficiencies to support long-term revenue and margin targets.

Summarized from source with an LLMView Source

Key figures

-7.80%1Y

44.2%3Y

56.1%5Y

Performance

25.8%1Y

24.6%3Y

27.7%5Y

Volatility